CCM
ABBV icon

CTC Capital Management’s AbbVie ABBV Stock Holding History

CTC Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,300
Closed -$1.65M – 98
2022
Q3 		$1.65M Buy
12,300
+10,700
+669% +$1.54M 1.32% 12
2022
Q2 		$245K Buy
+1,600
New +$244K 0.27% 58

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CTC Capital Management's ABBV Position: Q4 2022 in Review

CTC Capital Management sold out of AbbVie (ABBV) in Q4 2022, closing a stake of 12,300 shares — an estimated $1.65M sold.

CTC Capital Management first reported a position in ABBV in Q2 2022 and held it in 2 quarters. The position peaked at $1.65M in Q3 2022. 3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • CTC Capital Management reported no remaining AbbVie position as of Q4 2022 after selling out during the quarter.
  • CTC Capital Management sold 12,300 AbbVie shares in Q4 2022, an estimated $1.65M.
  • CTC Capital Management first reported a position in AbbVie in Q2 2022 and held it in 2 quarters.
  • CTC Capital Management's AbbVie position peaked at $1.65M in Q3 2022.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on CTC Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.